Difficulty: Medium
Average Score: 94%
Practice
Which of the following agents and dosage regimens is the best choice of treatment for an asthma patient with rheumatoid arthritis who is considered sensitive to aspirin (experiences bronchospasm with use)?
Correct answer
B
Rationale
In this scenario, the correct answer is option B) Acetaminophen, 650 mg every 4 hours. This choice is the best treatment for the asthma patient with rheumatoid arthritis who is sensitive to aspirin because acetaminophen is a non-steroidal anti-inflammatory drug (NSAID) that does not inhibit cyclooxygenase-1 (COX-1) enzyme like aspirin, which is responsible for bronchoconstriction in sensitive individuals.
Option A) Ibuprofen is also an NSAID and can potentially trigger bronchospasm in aspirin-sensitive individuals. Option C) Gold injections and Option D) Azathioprine are not indicated for the treatment of asthma or its related symptoms.
From an educational perspective, understanding the pharmacological properties of different drugs and their potential effects on patients with specific conditions is crucial for healthcare professionals. It is essential to consider individual patient factors, such as allergies and sensitivities, to ensure safe and effective treatment. This question highlights the importance of drug selection based on a patient's unique medical history and condition to optimize therapeutic outcomes while minimizing adverse effects.
Option A) Ibuprofen is also an NSAID and can potentially trigger bronchospasm in aspirin-sensitive individuals. Option C) Gold injections and Option D) Azathioprine are not indicated for the treatment of asthma or its related symptoms.
From an educational perspective, understanding the pharmacological properties of different drugs and their potential effects on patients with specific conditions is crucial for healthcare professionals. It is essential to consider individual patient factors, such as allergies and sensitivities, to ensure safe and effective treatment. This question highlights the importance of drug selection based on a patient's unique medical history and condition to optimize therapeutic outcomes while minimizing adverse effects.